Frontlight ResearchEarly access
Trial site
Koc Universitesi Hastanesi
- 10running trials
- 3closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Prostate cancer4 trials
- Fatty liver disease (MASLD/MASH)2 trials
- Obesity2 trials
- Chronic kidney disease1 trial
- Chronic myeloid leukaemia1 trial
- Liver cirrhosis1 trial
- Lung cancer1 trial
- Metastatic breast cancer1 trial
- Multiple myeloma1 trial
- Myelodysplastic syndromes1 trial
- Type 1 diabetes1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 310 trials
- Phase 22 trials
- Phase 11 trial
- Status
- Recruiting7 trials
- Active, not recruiting2 trials
- Completed2 trials
- Not yet recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Boehringer Ingelheim3 trials
- Janssen Research & Development, LLC3 trials
- Amgen2 trials
- Eli Lilly and Company2 trials
- Pfizer2 trials
- and 1 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Prostate cancer3 recruiting
- Fatty liver disease (MASLD/MASH)2 recruiting
- Liver cirrhosis1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Completed
Withdrawn
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026